Why the study?
Does the choice of HRQoL instrument (SF-6D vs 15D) affect the estimation of QALYs in STEMI patients randomized to early angioplasty versus standard management?
RCT (n=248)
randomized
Does the choice of HRQoL instrument (SF-6D vs 15D) affect the estimation of QALYs in STEMI patients randomized to early angioplasty versus standard management?
Answers are grounded in this paper and cite their sources.
The choice of HRQoL instrument (SF-6D vs 15D) influences absolute utility scores but does not significantly alter the estimated gain in QALYs between treatment arms.
OBJECTIVES: The aim of this study was to compare health-related quality of life (HRQoL) scores obtained from the instrument Short Form (SF)-36 through the so-called SF-6D utilities, and those obtained from 15D, in patients with ST-elevation myocardial infarction (STEMI), and to evaluate the consequences in estimation of quality adjusted life years (QALYs). DESIGN: This was a sub-study of the Norwegian District Treatment of STEMI, in which patients with STEMI treated with tenecteplase, were randomized to early angioplasty or standard management (n = 266). HRQoL data were collected at all visits (0, 1, 3, 7 and 12 months). All patients with complete data were included (n = 248). RESULTS: The score range was 0.33-1.0 for SF-6D and 0.49-1.0 for 15D. Mean utility scores from 15D were higher and had different distribution compared to scores from SF-6D. Mean QALY for the whole group was higher using 15D than SF-6D (0.89 vs. 0.77). The incremental number of QALYs with early angioplasty compared to standard treatment was 0.005 (95% CI: - 0.018 to 0.028) using SF-6D, and 0.004 (95% CI: - 0.010 to 0.018) using the 15D instrument. CONCLUSIONS: Choice of instrument may influence HRQoL scores, but not necessarily the gain in QALYs.
No takes yet. Share an insight, caveat, or question.
Bøhmer et al. (2014) conducted an RCT in ST-elevation myocardial infarction (STEMI) (n=248). Early angioplasty vs. Standard management was evaluated on Incremental number of quality adjusted life years (QALYs) (MD 0.005, 95% CI -0.018 to 0.028).
Synapse has enriched 10 related papers. Consider them for comparative context: